Merck Announces Second-Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Merck (MRK) Tops Q2 EPS by 14c, Raises FY Guidance
July 30, 2019 6:47 AM EDTMerck (NYSE: MRK) reported Q2 EPS of $1.30, $0.14 better than the analyst estimate of $1.16. Revenue for the quarter came in at $11.8 billion versus the consensus estimate of $10.96 billion.
GUIDANCE:
Merck sees FY2019 EPS of $4.84-$4.94, versus the consensus of $4.75. Merck sees... More
